Table A1.
Variable | Univariate analysis
|
Multivariate analysis CCQ
|
Multivariate analysis SGRQ
|
Multivariate analysis BORG
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | ||
Treatment arm | 0.980 | (0.519–1.851) | 0.950 | 1.086 | (0.472–2.502) | 0.846 | 1.228 | (0.549–2.749) | 0.616 | 1.159 | (0.690–3.666) | 0.276 | |
FEV1% predicted | 0.967 | (0.939–0.996) | 0.024 | 0.949 | (0.907–0.993) | 0.024 | 0.971 | (0.935–1.009) | 0.129 | 0.636 | (0.927–1.001) | 0.590 | |
Age | 1.007 | (0.969–1.047) | 0.720 | 1.003 | (0.952–1.056) | 0.918 | 1.019 | (0.963–1.078) | 0.512 | 1.010 | (0.956–1.068) | 0.715 | |
Male gender | 1.026 | (0.486–2.169) | 0.945 | 1.239 | (0.429–3.575) | 0.692 | 1.094 | (0.369–3.249) | 0.871 | 0.763 | (0.264–2.209) | 0.618 | |
Smoking status | 0.831 | (0.381–1.812) | 0.641 | 0.632 | (0.217–1.839) | 0.400 | 0.534 | (0.195–1.461) | 0.222 | 0.513 | (0.183–1.435) | 0.203 | |
Packyears | 0.990 | (0.974–1.007) | 0.258 | ||||||||||
Previous admission | 1.328 | (0.878–2.009) | 0.180 | ||||||||||
Previous admission > 2 | 2.283 | (0.810–6.438) | 0.119 | ||||||||||
O2 use at home | 2.923 | (1.449–5.897) | 0.003 | 0.952 | (0.3 12–2.905) | 0.932 | 1.821 | (0.702–4.725) | 0.218 | 2.430 | (0.923–6.398) | 0.072 | |
BMI | 0.986 | (0.925–1.052) | 0.671 | ||||||||||
BMI < 2I | 0.872 | (0.340–2.233) | 0.775 | ||||||||||
O2 sat | 1.000 | (0.969–1.032) | 0.997 | ||||||||||
O2 sat t1t2 | 0.957 | (0.879–1.042) | 0.307 | ||||||||||
pH | 0.038 | (0.001–1.323) | 0.071 | ||||||||||
pH t1t2 | 0.000 | (0.000–1.463) | 0.059 | ||||||||||
Pa, O2 | 0.939 | (0.804–1.097) | 0.429 | ||||||||||
Pa, O2t1t2 | 0.837 | (0.686–1.021) | 0.079 | ||||||||||
Pa, CO2 | 1.451 | (1.123–1.874) | 0.004 | 1.207 | (0.855–1.705) | 0.286 | 1.396 | (0.998–1.953) | 0.052 | 1.304 | (0.933–1.822) | 0.120 | |
Pa, CO2t1t2 | 1.003 | (0.717–1.403) | 0.986 | ||||||||||
HBCO | 0.946 | (0.711–1.260) | 0.705 | ||||||||||
HbCO t1t2 | 1.153 | (0.830–1.602) | 0.395 | ||||||||||
Hypoxaemia | 1.071 | (0.477–2.405) | 0.869 | ||||||||||
Hypercapnea | 0.544 | (0.165–1.793) | 0.317 | ||||||||||
Acidotic | 0.378 | (0.145–0.988) | 0.047 | ||||||||||
CRP | 1.000 | (0.996–1.004) | 0.921 | ||||||||||
ESR | 1.007 | (0.995–1.018) | 0.255 | ||||||||||
Glucose | 0.988 | (0.953–1.023) | 0.493 | ||||||||||
SGRQ total score | 0.978 | (0.959–0.999) | 0.037 | 0.979 | (0.954–1.004) | 0.098 | |||||||
SGRQ symptoms | 0.989 | (0.972–1.008) | 0.250 | ||||||||||
SGRQ impact | 0.980 | (0.961–1.000) | 0.045 | ||||||||||
SGRQ activity | 0.987 | (0.972–1.003) | 0.100 | ||||||||||
CCQ total | 0.217 | (0.943–1.757) | 0.294 | ||||||||||
CCQ symptoms | 0.927 | (0.678–1.267) | 0.633 | ||||||||||
CCQ functional status | 1.264 | (0.942–1.695) | 0.119 | ||||||||||
CCQ mental status | 1.144 | (0.932–1.402) | 0.198 | ||||||||||
CCQ tt1t2 | 0.062 | (0.072–0.929) | 0.017 | ||||||||||
CCQ st1t2 | 0.624 | (0.471–0.828) | 0.001 | 0.636 | (0.427–0.947) | 0.026 | |||||||
CCQ ft1t2 | 0.783 | (0.610–1.004) | 0.054 | ||||||||||
CCQ mt1t2 | 1.077 | (0.860–1.349) | 0.518 | ||||||||||
CCQ st1t2 > 0 | 0.339 | (0.171–0.671) | 0.002 | ||||||||||
BORG | 1.151 | (0.989–1.340) | 0.070 | ||||||||||
BORG t1t2 | 1.171 | (0.997–1.375) | 0.055 | 1.143 | (0.924–1.415) | 0.218 | |||||||
BORG t1t2 > 0 | 0.278 | (0.038–2.029) | 0.207 |
Abbreviations: BMI, body mass index; CI, confidence interval; CCQ, Clinical COPD Questionnaire; CSR, C-reactive protein; ESR, erythrocyte sedimentation rate; HR, hazard ratio; SGRQ, St George’s Respiratory Questionnaire; FEV1 forced expiratory flow in one second.